Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2002

View Archived Issues

DepoMed updates clinical status

Sangamo's ZFP technology used to show control of fat cell development

FDA upgrades pregnancy rating for AstraZeneca's Pulmicort Turbuhaler asthma medication

Neurogen and Aventis collaborate to develop CRF1 drugs for depression, anxiety and stress disorders

BioCryst resumes phase III trial of peramivir for the treatment of influenza

IDE filed for Batimastat BiodivYsio stent; enters pivotal phase II trial

Phase II preliminary results of Neurogen's NGD-91-3 for general anxiety disorder

Continuous infusion of Amylin's AC-2993 shown to reduce glucose concentrations over 24 hours

E.U. and U.S. orphan drug designation for Transkaryotic Therapies' Hunter's syndrome treatment

Shire and HydroMed realign histrelin agreement

Oxis Turbuhaler receives pediatric license in the EU

HMR-3270, a new promising antifungal candin

Antirhinoviral compounds reported by Essential Therapeutics

Indole and chromene derivatives with potent antibacterial activity patented by Roche

Nippon Chemiphar designs new PPARdelta receptor agonists

Novel bacterial RNA polymerase inhibitors patented by Tularik

Cor Therapeutics reports new series of platelet ADP receptor inhibitors

GSK-3 inhibitors reported to be useful for Alzheimer's disease

CDK inhibitors useful as anticancer agents reported by LG Chem

Antiviral pyrimidine nucleoside analogues disclosed by university researchers

Motilin antagonists disclosed at Ortho-McNeil

Novel lantibiotics reported at ICAAC

GSQ-5028 selected to demonstrate the mechanism of action of HARPs

CP-642959: a new oxime ether ketolide with promising activity

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...